Michael Vergano - Imagin Medical Director of Operations

All Insiders . USA . 
Stock . Imagin Medical . Stakeholders . Insider . Michael Vergano
IMEXF Stock  USD 0.0001  0.00  0.00%   

Director

Mr. Michael G. Vergano is Director of Operations of the Company. He was president of The Harvest Group Inc. since 1998, where he has provided consulting services for startups and major corporations in all phases of project management, including product development, packaging, quality systems, operations, manufacturing engineering, and systemprocess design and validation. During his more than 30 years in the medical device industry, Mr. Vergano also held management positions at Apple Medical, Inc. Ciba Corning Diagnostics, Microsurge, Inc. and Boston Scientific Corporationrationration. He is the holder of 11 medical device patents since 2016.
Tenure 8 years
Phone833 246 2446
Webhttps://imaginmedical.com
Vergano holds a BS in Mechanical Engineering from Tufts University.

Imagin Medical Management Efficiency

The company has return on total asset (ROA) of (2.3654) % which means that it has lost $2.3654 on every $100 spent on assets. This is way below average. Imagin Medical's management efficiency ratios could be used to measure how well Imagin Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Imagin Medical has accumulated 8.95 M in total debt with debt to equity ratio (D/E) of 2.1, implying the company greatly relies on financing operations through barrowing. Imagin Medical has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Imagin Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Imagin Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Imagin Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Imagin to invest in growth at high rates of return. When we think about Imagin Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Donna JamesBoston Scientific Corp
63
David RouxBoston Scientific Corp
67
Yoshiaki FujimoriBoston Scientific Corp
69
Nelda ConnorsBoston Scientific Corp
55
Lainie CortenCerus
N/A
John SununuBoston Scientific Corp
56
Ellen ZaneBoston Scientific Corp
69
Yves JongenIon Beam Applications
76
Kenji FurukawaNihon Kohden Corp
N/A
Edward LudwigBoston Scientific Corp
69
Hiroyuki SatakeNihon Kohden Corp
65
Yasuhiro YoshitakeNihon Kohden Corp
57
David WichmannBoston Scientific Corp
58
Charles DockendorffBoston Scientific Corp
66
Fumio HiroseNihon Kohden Corp
63
Tadashi HasegawaNihon Kohden Corp
64
Takashi TamuraNihon Kohden Corp
64
Stephen MacMillanBoston Scientific Corp
56
Imagin Medical Inc. operates as a surgical imaging company focusing on bladder cancer. Imagin Medical Inc. was founded in 1986 and is headquartered in Vancouver, Canada. Imagin Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. Imagin Medical [IMEXF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Asset-2.37

Imagin Medical Management Team

Elected by the shareholders, the Imagin Medical's board of directors comprises two types of representatives: Imagin Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imagin. The board's role is to monitor Imagin Medical's management team and ensure that shareholders' interests are well served. Imagin Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imagin Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Edward Hutchens, Pres CEO
Michael Vergano, Director of Operations
John CPA, Corp CFO

Imagin Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Imagin Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-2.37
Current Valuation7.9 M
Shares Outstanding10.83 M
Shares Owned By Insiders12.46 %
Price To Earning(3.47) X
Price To Book9.05 X
EBITDA(2.44 M)
Net Income(2.49 M)
Cash And Equivalents145.67 K
Cash Per Share0.01 X

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Imagin Pink Sheet

Imagin Medical financial ratios help investors to determine whether Imagin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Imagin with respect to the benefits of owning Imagin Medical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY